- Home
- JRSH vs TPST Comparison
JRSH vs TPST Comparison
Compare JRSH & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JRSH
- TPST
- Stock Information
- Founded
- JRSH 2016
- TPST 2011
- Country
- JRSH United States
- TPST United States
- Employees
- JRSH N/A
- TPST N/A
- Industry
- JRSH Apparel
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- JRSH Consumer Discretionary
- TPST Health Care
- Exchange
- JRSH Nasdaq
- TPST Nasdaq
- Market Cap
- JRSH 41.7M
- TPST 45.5M
- IPO Year
- JRSH 2018
- TPST N/A
- Fundamental
- Price
- JRSH $3.27
- TPST $10.88
- Analyst Decision
- JRSH Strong Buy
- TPST Hold
- Analyst Count
- JRSH 1
- TPST 3
- Target Price
- JRSH $4.00
- TPST $30.00
- AVG Volume (30 Days)
- JRSH 124.5K
- TPST 45.5K
- Earning Date
- JRSH 11-11-2025
- TPST 11-11-2025
- Dividend Yield
- JRSH 6.12%
- TPST N/A
- EPS Growth
- JRSH N/A
- TPST N/A
- EPS
- JRSH 0.07
- TPST N/A
- Revenue
- JRSH $144,505,598.00
- TPST N/A
- Revenue This Year
- JRSH $7.62
- TPST N/A
- Revenue Next Year
- JRSH $8.35
- TPST N/A
- P/E Ratio
- JRSH $49.84
- TPST N/A
- Revenue Growth
- JRSH 17.11
- TPST N/A
- 52 Week Low
- JRSH $2.81
- TPST $5.35
- 52 Week High
- JRSH $4.17
- TPST $20.67
- Technical
- Relative Strength Index (RSI)
- JRSH 46.71
- TPST 58.22
- Support Level
- JRSH $3.23
- TPST $8.87
- Resistance Level
- JRSH $3.35
- TPST $11.07
- Average True Range (ATR)
- JRSH 0.10
- TPST 0.47
- MACD
- JRSH -0.01
- TPST 0.07
- Stochastic Oscillator
- JRSH 38.09
- TPST 87.66
About JRSH Jerash Holdings (US) Inc.
Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.